252 related articles for article (PubMed ID: 15815734)
1. [Should older men be treated with testosterone?].
Svartberg J
Tidsskr Nor Laegeforen; 2005 Apr; 125(7):879-82. PubMed ID: 15815734
[TBL] [Abstract][Full Text] [Related]
2. Testosterone in older men after the Institute of Medicine Report: where do we go from here?
Harman SM
Climacteric; 2005 Jun; 8(2):124-35. PubMed ID: 16096168
[TBL] [Abstract][Full Text] [Related]
3. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel.
Swerdloff RS; Wang C
Aging Male; 2003 Sep; 6(3):207-11. PubMed ID: 14628501
[TBL] [Abstract][Full Text] [Related]
4. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
[TBL] [Abstract][Full Text] [Related]
5. [Testosterone substitution in patients with hypogonadism].
Martínez Portillo FJ; Cueva Martínez A; Martin Braun P; Fernández Arancibia MI; Jünemann KP; Alken P
Arch Esp Urol; 2002 Sep; 55(7):827-38. PubMed ID: 12380312
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
7. Androgens and the ageing male.
Swerdloff RS; Wang C
Best Pract Res Clin Endocrinol Metab; 2004 Sep; 18(3):349-62. PubMed ID: 15261842
[TBL] [Abstract][Full Text] [Related]
8. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
Johansen KL
Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
[TBL] [Abstract][Full Text] [Related]
9. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.
Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Berman N; Hull L; Swerdloff RS
J Clin Endocrinol Metab; 2004 May; 89(5):2085-98. PubMed ID: 15126525
[TBL] [Abstract][Full Text] [Related]
10. Defining 'relative' androgen deficiency in aging men: how should testosterone be measured and what are the relationships between androgen levels and physical, sexual and emotional health?
Haren MT; Morley JE; Chapman IM; O'Loughlin PD; Wittert GA
Climacteric; 2002 Mar; 5(1):15-25. PubMed ID: 11974555
[TBL] [Abstract][Full Text] [Related]
11. Testosterone treatment in elderly men.
Srinivas-Shankar U; Sharma D
Adv Ther; 2009 Jan; 26(1):25-39. PubMed ID: 19198768
[TBL] [Abstract][Full Text] [Related]
12. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
13. Declining testicular function in aging men.
Tenover JS
Int J Impot Res; 2003 Aug; 15 Suppl 4():S3-8. PubMed ID: 12934044
[TBL] [Abstract][Full Text] [Related]
14. Increased incidence of diagnosed depressive illness in hypogonadal older men.
Shores MM; Sloan KL; Matsumoto AM; Moceri VM; Felker B; Kivlahan DR
Arch Gen Psychiatry; 2004 Feb; 61(2):162-7. PubMed ID: 14757592
[TBL] [Abstract][Full Text] [Related]
15. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
Behre HM; Heinemann L; Morales A; Pexman-Fieth C
Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
[TBL] [Abstract][Full Text] [Related]
17. Testosterone and body functions.
Köhn FM
Aging Male; 2006 Dec; 9(4):183-8. PubMed ID: 17178552
[TBL] [Abstract][Full Text] [Related]
18. Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects.
Schubert M; Jockenhövel F
J Endocrinol Invest; 2005; 28(3 Suppl):23-7. PubMed ID: 16042356
[TBL] [Abstract][Full Text] [Related]
19. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
Lunenfeld B; Saad F; Hoesl CE
Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
[TBL] [Abstract][Full Text] [Related]
20. Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip.
Svartberg J; Agledahl I; Figenschau Y; Sildnes T; Waterloo K; Jorde R
Int J Impot Res; 2008; 20(4):378-87. PubMed ID: 18480825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
